BioCardia (BCDA) director Andrew Blank awarded 8,000 stock options at $1.20
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BioCardia director Andrew Scott Blank received an option grant for 8,000 shares of common stock. The stock option has an exercise price of $1.20 per share and expires on July 6, 2036. Following this grant, Blank holds 23,313 derivative securities representing options. According to the footnote, all 8,000 option shares vest and become exercisable on the one-year anniversary of the grant date, provided he continues as a service provider through that date.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Blank Andrew Scott
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 8,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 23,313 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Option grant size: 8,000 options
Exercise price: $1.20 per share
Expiration date: July 6, 2036
+1 more
4 metrics
Option grant size
8,000 options
Stock Option (right to buy) granted to director
Exercise price
$1.20 per share
Exercise price of option grant
Expiration date
July 6, 2036
Option expiration date
Holdings after grant
23,313 derivative securities
Total options held following transaction
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date
4 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "1.2000" per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares are subject to the option vesting and becoming exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-07-06T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What did BioCardia (BCDA) director Andrew Scott Blank report on this Form 4?
Andrew Scott Blank reported receiving a grant of stock options for 8,000 shares of BioCardia common stock. These options are a form of equity compensation and give him the right to buy shares at a fixed exercise price if they vest.
What are the key terms of Andrew Scott Blank’s BioCardia (BCDA) stock option grant?
The grant covers 8,000 shares of common stock with an exercise price of $1.20 per share and an expiration date of July 6, 2036. These terms define the cost to exercise and the period during which the option can be used.
When do Andrew Scott Blank’s BioCardia (BCDA) options vest?
All 8,000 option shares vest and become exercisable on the one-year anniversary of the grant date. Vesting is conditioned on Blank continuing as a service provider to BioCardia through that one-year vesting date, according to the footnote.
How many derivative securities does Andrew Scott Blank hold after this BioCardia (BCDA) transaction?
After the option grant, Blank holds a total of 23,313 derivative securities. This total reflects his options position reported in the filing and shows his cumulative option-based exposure to BioCardia shares after the award.
Is Andrew Scott Blank’s BioCardia (BCDA) Form 4 transaction an open-market purchase or sale?
No, the Form 4 reports a grant of stock options as compensation, not an open-market trade. The transaction code is “A,” indicating a grant or award acquisition rather than buying or selling BioCardia shares in the market.